The Shotlee Journal
Browse Shotlee articles about Mounjaro.
Showing 9 / 801 Mounjaro articles
Jefferies has reiterated its Buy rating on Eli Lilly stock with a $1,300 price target, citing encouraging GLP-1 prescription data for the week ending March 13. Oral Wegovy showed strong performance in its 10th launch week, outpacing comparable injectables like Zepbound and Wegovy. Meanwhile, other GLP-1s saw slight declines amid Lilly's promising pipeline.
Charles Barkley's noticeably slimmer figure courtside during March Madness 2026 has sparked widespread speculation: Is Ozempic behind his weight loss? The NBA legend dropped nearly 90 pounds using GLP-1 drugs like Mounjaro and Zepbound, combined with diet and exercise. Fans are stunned, but Barkley credits hard work over hype.
Popular GLP-1 drugs like semaglutide and tirzepatide offer heart health benefits for type 2 diabetes patients, but stopping them may reverse these gains. A Washington University study of over 333,000 veterans revealed up to 22% higher risk of heart attacks and strokes after discontinuation. Continuous use provides up to 18% risk reduction—here's what it means for long-term treatment.
GLP-1 drugs like Ozempic and Wegovy are reshaping eating habits, slashing demand for pastries while surging sales of protein-rich yogurt and cottage cheese. Studies show users cut grocery spending by 6-9%, favoring nutrient-dense dairy. Dairy giants like Arla and Ehrmann are capitalizing with GLP-1-friendly products.
A legal 'loophole' is fueling a boom in unregulated injectable peptides sold online as 'research only' products, despite warnings they're unsafe for human use. Fitness enthusiasts inject BPC-157 and TB-500 for healing, while unapproved Retatrutide draws weight loss seekers. Experts urge caution amid contamination risks and MHRA crackdowns.
A St. Johns County man, Adam K. Taylor, is now facing federal misdemeanor charges for misbranding and selling off-brand versions of Ozempic (semaglutide) and other GLP-1 drugs without prescriptions. Operating AKT Labs as 'research purposes only,' he instructed undercover officers on weight loss use. This case highlights dangers of unregulated peptides sourced from China.
When celebrities drop dress sizes fast, whispers of 'fat jabs' like Ozempic fill the air—but stars stay mum. A veteran celeb agent exposes the regulatory pitfalls, contract traps, and multimillion-dollar reasons behind the secrecy. From TV bans to brand conflicts, here's why honesty could cost them dearly.
Semaglutide prices in India are poised for a dramatic drop to one-fourth of current levels following patent expiry on March 20. Generics from seven companies like Sun Pharma and Zydus Lifesciences will make Ozempic and Wegovy alternatives more accessible for diabetes and obesity management. Experts highlight improved adherence but warn of misuse risks.
Sydney's superstar chef Neil Perry, behind Gran Torino, Margaret, and Qantas menus, isn't fazed by the Ozempic craze. He pledges to continue creating beautiful food for those who love to eat. In a bold GLP-1 warning, Perry hints at potential lawsuits ahead.
